• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Different distribution of two types of angiotensin II-generating enzymes in the aortic wall.

作者信息

Okunishi H, Miyazaki M, Okamura T, Toda N

机构信息

Department of Pharmacology, Shiga University of Medical Science, Otsu, Japan.

出版信息

Biochem Biophys Res Commun. 1987 Dec 31;149(3):1186-92. doi: 10.1016/0006-291x(87)90533-x.

DOI:10.1016/0006-291x(87)90533-x
PMID:2827656
Abstract

Dog, monkey and human aortic tissues contained two distinct types of angiotensin II-generating enzymes; angiotensin converting enzyme (ACE) and chymostatin-sensitive angiotensin II-generating enzyme (CAGE). Endothelium, media and adventitia of canine thoracic aortae were separated using collagenase digestion, and determined for their ACE and CAGE activity. ACE activity was assayed by hippuryl-His-Leu cleavage. CAGE activity was estimated with ANG I as substrate in the presence of inhibitors of ACE and angiotensinases. His-Leu, the common product of both enzyme reactions, was fluorimetrically quantified after o-phthalaldehyde condensation. ACE localized mainly in endothelium, while CAGE distributed predominantly in adventitia. Similar results were obtained with human and monkey aortae. Such a contrasting distribution may indicate the distinct functional role of these two enzymes.

摘要

相似文献

1
Different distribution of two types of angiotensin II-generating enzymes in the aortic wall.
Biochem Biophys Res Commun. 1987 Dec 31;149(3):1186-92. doi: 10.1016/0006-291x(87)90533-x.
2
Possible roles of angiotensin II-forming enzymes, angiotensin converting enzyme and chymase-like enzyme, in the human aneurysmal aorta.血管紧张素II生成酶、血管紧张素转换酶和类糜酶在人类动脉瘤性主动脉中的可能作用。
Hypertens Res. 2002 Nov;25(6):817-22. doi: 10.1291/hypres.25.817.
3
Conversion of angiotensin I to angiotensin II in dog isolated renal artery: role of two different angiotensin II-generating enzymes.犬离体肾动脉中血管紧张素I向血管紧张素II的转化:两种不同血管紧张素II生成酶的作用。
J Cardiovasc Pharmacol. 1990 Mar;15(3):353-9. doi: 10.1097/00005344-199003000-00002.
4
Functional role, cellular source, and tissue distribution of rat elastase-2, an angiotensin II-forming enzyme.
Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H775-83. doi: 10.1152/ajpheart.00818.2002. Epub 2003 Apr 24.
5
Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.心脏血管紧张素II的形成:血管紧张素I转换酶与人类组织蛋白酶
Eur Heart J. 1993 Nov;14 Suppl I:177-82.
6
Presence of angiotensin converting enzyme in the adventitia of large blood vessels.
J Hypertens. 1992 Jul;10(7):615-20.
7
Angiotensin-converting enzyme substrates hydrolyzed by fibroblasts and vascular endothelial cells.成纤维细胞和血管内皮细胞水解的血管紧张素转换酶底物。
Exp Lung Res. 1982 May;3(2):137-45. doi: 10.3109/01902148209063288.
8
Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.培哚普利可长期抑制缺血性心脏病患者乳内动脉内皮和外膜中的血管紧张素转换酶。
Circulation. 1997 Jul 1;96(1):174-82.
9
Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart.放射性配体结合实验表明,在正常人体心脏中,糜酶是介导血管紧张素I组织转化的主要酶。
Clin Sci (Lond). 2002 Jan;102(1):15-21.
10
Influence of vascular smooth muscle heterogeneity on angiotensin converting enzyme activity in chicken embryonic aorta and in endothelial cells in culture.血管平滑肌异质性对鸡胚主动脉及培养内皮细胞中血管紧张素转换酶活性的影响。
Circ Res. 1992 Oct;71(4):923-31. doi: 10.1161/01.res.71.4.923.

引用本文的文献

1
Chymase Dependent Pathway of Angiotensin II Generation and Rapeseed Derived Peptides for Antihypertensive Treatment of Spontaneously Hypertensive Rats.血管紧张素II生成的糜酶依赖性途径及油菜籽衍生肽对自发性高血压大鼠的降压治疗
Front Pharmacol. 2021 May 17;12:658805. doi: 10.3389/fphar.2021.658805. eCollection 2021.
2
Involvement of mast cell chymase in burn wound healing in hamsters.肥大细胞糜蛋白酶在仓鼠烧伤创面愈合中的作用
Exp Ther Med. 2013 Feb;5(2):643-647. doi: 10.3892/etm.2012.836. Epub 2012 Nov 27.
3
A new experimental approach in endothelium-dependent pharmacological investigations on isolated porcine coronary arteries mounted for impedance planimetry.
一种用于对安装好以进行阻抗平面测量的离体猪冠状动脉进行内皮依赖性药理学研究的新实验方法。
Br J Pharmacol. 1999 Sep;128(1):165-73. doi: 10.1038/sj.bjp.0702752.
4
Cloning of the gene and cDNA for hamster chymase 2, and expression of chymase 1, chymase 2 and angiotensin-converting enzyme in the terminal stage of cardiomyopathic hearts.仓鼠糜蛋白酶2基因和cDNA的克隆,以及糜蛋白酶1、糜蛋白酶2和血管紧张素转换酶在心肌病晚期心脏中的表达。
Biochem J. 1998 Jul 15;333 ( Pt 2)(Pt 2):417-24. doi: 10.1042/bj3330417.
5
Combination therapy with an angiotensin converting enzyme inhibitor and an angiotensin-II receptor antagonist for refractory essential hypertension.血管紧张素转换酶抑制剂与血管紧张素 II 受体拮抗剂联合治疗难治性原发性高血压。
West J Med. 1998 Apr;168(4):272-4.
6
Captopril does not acutely modulate plasma endothelin-1 concentration in human congestive heart failure.
Cardiovasc Drugs Ther. 1996 Nov;10(5):561-5. doi: 10.1007/BF00050997.
7
Humoral and haemodynamic effects of idrapril calcium, the prototype of a new class of ACE-inhibitors, in essential hypertensive patients.新型ACE抑制剂类原型药依那普利钙对原发性高血压患者的体液和血流动力学影响
Eur J Clin Pharmacol. 1995;48(5):339-43. doi: 10.1007/BF00194948.
8
Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.血管紧张素II受体拮抗剂在心力衰竭中的应用:氯沙坦对老年人疗效评估(ELITE)试验的理论依据与设计
Cardiovasc Drugs Ther. 1995 Oct;9(5):693-700. doi: 10.1007/BF00878552.
9
Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.新型非肽类血管紧张素II受体拮抗剂BIBR 277的药理学特性
Br J Pharmacol. 1993 Sep;110(1):245-52. doi: 10.1111/j.1476-5381.1993.tb13800.x.
10
Angiotensin converting enzyme activity is present in the endothelium-denuded aorta.血管紧张素转换酶活性存在于内皮剥脱的主动脉中。
Br J Pharmacol. 1989 Oct;98(2):333-5. doi: 10.1111/j.1476-5381.1989.tb12599.x.